Jeff Bezos backs tiny biotech with $130 mil investment

[Eagle Financial Publications] Below please find a special message from one of our sponsors, Behind the Markets. From time to time we find special opportunities we believe you as a valued customer may want to see. Please note that the following message reflects the opinions and representations of our sponsor alone, and not necessarily the opinion or editorial positions of Eagle Financial Publications or Salem Communications. Fellow Investor, A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda. And they have a clean balance sheet with over $1 billion in cash to fund their efforts. Now, investors are lining up to buy shares. Stock purchases by institutional buyers more than doubled in the last quarter of 2023. What is it about this stock that has everyone excited? [Find out more here ]( "The Buck Stops Here," Dylan Jovine, CEO & Founder Behind the Markets --------------------------------------------------------------- To ensure future delivery of Eagle Financial Publication's emails please add the domain @mail.eaglefinancialpublications.com to your address book or contact list. This email was sent to {EMAIL} because you are subscribed to the Carefully Selected Financial Offers from Third Parties List. To unsubscribe please click [here](. To stop receiving emails simply click [here](. View this email in your [web browser](. If you have questions, please send them to [Customer Service](mailto:customerservice@eaglefinancialpublications.com). Eagle Financial Publications - Eagle Products, LLC. - a Salem Communications Holding Company 122 C Street NW, Suite 515 | Washington, D.C. 20001 © Eagle Financial Publications. All rights reserved. [Link](